Home › Funds › CADIAN CAPITAL MANAGEMENT, LP › GH

CADIAN CAPITAL MANAGEMENT, LP position in GH

GUARDANT HEALTH INC · Health Care

CADIAN CAPITAL MANAGEMENT, LP reported holding 757,393 shares of GH (GUARDANT HEALTH INC) in its Q2 2026 13F filing — a position valued at US$113.6M, representing 8.60% of its reported portfolio and ranking #2 among its reported holdings. CADIAN CAPITAL MANAGEMENT, LP has disclosed GH holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)757.39K sh
Reported value held$113.63M
Portfolio Weight8.60%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CADIAN CAPITAL MANAGEMENT, LP's GH position evolved

CADIAN CAPITAL MANAGEMENT, LP first disclosed a stake in GH in Q4 2023 at 710,000 shares (US$19.2M). The position peaked in Q1 2025 at 4,595,087 shares, worth US$195.8M. Across 11 filings, CADIAN CAPITAL MANAGEMENT, LP increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 757,393 shares valued at US$113.6M — a reduction of -22,255 shares quarter over quarter.. Notable position changes include a 716% increase in Q1 2024 (shares rose 40% over the following quarter), a 98% trim in Q3 2024 (shares rose 33% over the following quarter), a 6638% increase in Q4 2024 (shares rose 39% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 710.00K $19.21M New
Q1 2024 5.79M $119.51M Add
Q2 2024 3.13M $90.45M Reduce
Q3 2024 77.50K $1.78M Reduce
Q4 2024 5.22M $159.52M Add
Q1 2025 4.60M $195.75M Reduce
Q2 2025 3.18M $165.45M Reduce
Q3 2025 2.14M $133.78M Reduce
Q4 2025 922.63K $94.24M Reduce
Q1 2026 779.65K $72.02M Reduce
Q2 2026 757.39K $113.63M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GH and 13F data

GH (GUARDANT HEALTH INC) is a Health Care company. 57 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$509.1M), FULLER & THALER ASSET MANAGEMENT, INC. (US$394.4M), EVENTIDE ASSET MANAGEMENT, LLC (US$293.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GH

All GH fund holders →

FAQ

How long has CADIAN CAPITAL MANAGEMENT, LP held GH?

CADIAN CAPITAL MANAGEMENT, LP has disclosed GH holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is CADIAN CAPITAL MANAGEMENT, LP's current position in GH?

As of Q2 2026, CADIAN CAPITAL MANAGEMENT, LP holds 757.39K shares of GH (GUARDANT HEALTH INC), valued at $113.63M, representing 8.60% of its reported portfolio and ranking #2.

Has CADIAN CAPITAL MANAGEMENT, LP been buying or selling GH?

In the latest 13F filing (Q2 2026), CADIAN CAPITAL MANAGEMENT, LP reduced its position in GH. The position peaked in Q1 2025 at 4.60M shares.

Which other funds hold GH?

Other major institutional holders of GH include Deep Track Capital, LP, FULLER & THALER ASSET MANAGEMENT, INC., EVENTIDE ASSET MANAGEMENT, LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.